InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

InspireMD, Inc.

NSPR Clue Score57
United States Fiscal year ends December CIK 0001433607 Results filed 17 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Paul Stuka
27 May 2026
Director
Buy
20,000
$0.88
$17.50K
Shane Thomas Gleason
19 May 2026
Chief Commercial Officer
Sell
22,778
$1.01
$23.01K
Paul Stuka
14 May 2026
Director
Buy
5,000
$1.15
$5.75K
Paul Stuka
13 May 2026
Director
Buy
10,000
$1.16
$11.58K
Marvin Slosman
12 May 2026
CEO and President
Buy
21,000
$1.20
$25.20K
Paul Stuka
11 May 2026
Director
Buy
10,000
$1.19
$11.90K
Paul Stuka
8 May 2026
Director
Buy
65,626
$1.16
$76.13K
Gary S Roubin
7 May 2026
Director
Buy
90,000
$1.18
$106.20K
Paul Stuka
7 May 2026
Director
Buy
6,378
$1.15
$7.33K
Scott R. Ward
7 May 2026
Director
Buy
73,255
$1.15
$84.24K
Paul Stuka
6 May 2026
Director
Buy
1,517
$1.12
$1.70K
Scott R. Ward
6 May 2026
Director
Buy
15,995
$1.15
$18.39K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,000
$1.60
$3.21K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,941
$1.59
$4.68K
Shane Thomas Gleason
30 Jan 2026
Chief Commercial Officer
Sell
2,900
$1.63
$4.73K
Shane Thomas Gleason
29 Jan 2026
Chief Commercial Officer
Sell
5,000
$1.65
$8.25K
Shane Thomas Gleason
28 Jan 2026
Chief Commercial Officer
Sell
12,395
$1.65
$20.46K
Shane Thomas Gleason
27 Jan 2026
Chief Commercial Officer
Sell
4,781
$1.66
$7.96K
Shane Thomas Gleason
22 Jan 2026
Chief Commercial Officer
Sell
8,411
$1.57
$13.24K
Shane Thomas Gleason
21 Jan 2026
Chief Commercial Officer
Sell
17,593
$1.62
$28.55K
Shane Thomas Gleason
20 Jan 2026
Chief Commercial Officer
Sell
2,955
$1.59
$4.71K
Shane Thomas Gleason
16 Jan 2026
Chief Commercial Officer
Sell
2,250
$1.61
$3.63K
Shane Thomas Gleason
15 Jan 2026
Chief Commercial Officer
Sell
2,909
$1.58
$4.59K
Paul Stuka
9 Dec 2025
Director
Buy
5,073
$1.81
$9.18K
Paul Stuka
5 Dec 2025
Director
Buy
5,073
$1.86
$9.44K
Paul Stuka
4 Dec 2025
Director
Buy
10,130
$1.85
$18.74K
Paul Stuka
12 Nov 2025
Director
Buy
13,431
$1.62
$21.76K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 2,561,423
History held since 15 Jun 2011